| Elizabeth Duvall, MD | |
|
3601 W 13 Mile Rd, Royal Oak, MI 48073-6712 | |
| (248) 898-5000 | |
| Not Available |
| Full Name | Elizabeth Duvall |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 3601 W 13 Mile Rd, Royal Oak, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497249957 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4351036947 (Michigan) | Primary |
| Entity Name | Somerset Ophthalmology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497789473 PECOS PAC ID: 1557324928 Enrollment ID: O20041105001118 |
News Archive
In 2008 Ms. Berkley helped lead an effort to block a move by federal regulators to close Nevada's only kidney transplant center, which her husband's medical practice helps run under a $738,000-a-year contract. She also successfully pushed regulators, as recently as March, to reverse a plan to cut Medicare reimbursement to dialysis centers, including the dozen her husband's medical practice owns.
About 12 percent of patients who receive implantable cardiac devices such as a pacemaker or defibrillator and fill an opioid prescription after surgery will consistently use the pain medication in the months afterward, raising the potential for addiction following these common procedures and identifying another pathway that could contribute to the national opioid crisis, according to a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania.
David H. Fater, CEO of Vicor Technologies, Inc., today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and trauma victims in need of lifesaving intervention.
A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) system in an attempt to reduce permanent damage to their heart muscle.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Duvall, MD 3601 W 13 Mile Rd, Royal Oak, MI 48073-6712 Ph: (248) 898-5000 | Elizabeth Duvall, MD 3601 W 13 Mile Rd, Royal Oak, MI 48073-6712 Ph: (248) 898-5000 |
News Archive
In 2008 Ms. Berkley helped lead an effort to block a move by federal regulators to close Nevada's only kidney transplant center, which her husband's medical practice helps run under a $738,000-a-year contract. She also successfully pushed regulators, as recently as March, to reverse a plan to cut Medicare reimbursement to dialysis centers, including the dozen her husband's medical practice owns.
About 12 percent of patients who receive implantable cardiac devices such as a pacemaker or defibrillator and fill an opioid prescription after surgery will consistently use the pain medication in the months afterward, raising the potential for addiction following these common procedures and identifying another pathway that could contribute to the national opioid crisis, according to a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania.
David H. Fater, CEO of Vicor Technologies, Inc., today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and trauma victims in need of lifesaving intervention.
A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) system in an attempt to reduce permanent damage to their heart muscle.
› Verified 7 days ago
Tedi Begaj, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3555 W 13 Mile Rd Ste Ll-20, Royal Oak, MI 48073 Phone: 248-288-2280 | |
Dr. Robert J Mcdonald, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 32000 Woodward Ave, Royal Oak, MI 48073 Phone: 248-549-6000 Fax: 248-549-4923 | |
Huiyan Jin, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3535 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3643 | |
Dr. Sahal H. Saleh, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3000 | |
Dr. George R Lesser, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3535 W 13 Mile Rd, Suite 645, Royal Oak, MI 48073 Phone: 248-220-5252 Fax: 248-220-5261 | |
Dr. Tarek Shawky Hassan, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3555 W 13 Mile Rd, Ll-20, Royal Oak, MI 48073 Phone: 248-288-2280 Fax: 248-288-5644 | |
Dr. Safa Arfeen, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd Ofc, Royal Oak, MI 48073 Phone: 248-551-6347 |